We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Shares of Certara, Inc. (NASDAQ:CERT – Get Free Report) have earned an average recommendation of “Hold” from the eight research firms that are currently covering the company, Marketbeat reports. Six ...

In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Certara (CERT – Research Report), with a price ...

Stock analysts at William Blair increased their FY2024 earnings per share estimates for shares of Certara in a report issued on Wednesday, January 15th. William Blair analyst M. Smock now anticipates ...

In a report released yesterday, Michael Ryskin from Bank of America Securities maintained a Buy rating on Certara (CERT – Research Report), with a price target of $15.00. Discover outperforming ...

In trading on Wednesday, shares of Certara Inc (Symbol: CERT) crossed above their 200 day moving average of $13.29, changing hands as high as $13.68 per share. Certara Inc shares are currently ...

RADNOR, Pa., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced revenue and bookings for the fourth quarter and ...

Certara reports 2024 revenue of $384.4 million, bookings of $445.3 million, and confirms adjusted EBITDA guidance of $120-$124 million. Certara, Inc. reported preliminary financial results for ...